Out of sync: HCV-disrupted transcriptional oscillation is a driver of liver disease and cancer

A pioneering new study published in Nature Communications, has identified the human circadian transcriptome of the liver and shed light on the complex interplay between the hepatitis C virus (HCV) and the human liver's circadian rhythm contributing to the development of liver disease and cancer.
Out of sync: HCV-disrupted transcriptional oscillation is a driver of liver disease and cancer
Like

Share this post

Choose a social network to share with, or copy the URL to share elsewhere

This is a representation of how your post may appear on social media. The actual post will vary between social networks

Despite an efficient antiviral therapy, chronic Hepatitis C virus infection (CHC) and associated liver complications remain being an important global health burden. CHC perturbs liver functions by causing chronic inflammation, metabolic disorder, fibrosis, and hepatocellular carcinoma (HCC). The liver is a highly circadian organ with precisely timed physiologic functions throughout the day. While well studied in rodent models, our understanding of the rhythmic expression of genes (regulated by the circadian clock) in human disease is still evolving.

A rhythmic symphony of genes

To identify rhythmic transcriptome and epigenome of human hepatocytes, the study used human liver chimeric mice. This unique model allows the study human liver tissue in a living animal, providing valuable insights into the natural behaviour of human cells. Using advanced bioinformatic algorithms the analyses identified a vast array of rhythmically expressed protein-coding genes, including key transcription factors and chromatin modifiers, which are important regulators of liver homeostasis.

The viral hijack: HCV's disruption of rhythmic pathways

The study revealed that liver pathogens like HCV infection perturb the hepatic transcriptome. By altering the rhythmicity of over 1000 genes, HCV disrupts the regulation of gene expression, leading to a cascade of downstream effects. Moreover, HCV infection of human hepatocytes also impacts the epigenome on the level of chemical histone modifications that influence gene activity. The study revealed that HCV-associated epigenetic disruption activates critical pathways involved in metabolic alterations, fibrosis, and ultimately, cancer.

Clinical Implications and Future Directions

The findings of the study have profound clinical implications. By understanding how HCV perturbs the hepatic rhythmic pathways, we can gain valuable insights into the mechanisms underlying cancer development. This knowledge may pave the way for the development of novel biomarkers and therapeutic strategies aimed at predicting the risk of disease progression and preventing liver cancer development in patients at elevated risk and thus lead to novel tools for better diagnosis and personalized treatments.

Conclusion

The findings of this study identified a novel, previously unrecognized way by which HCV infection causes liver disease progression towards cancer. By unravelling the complex interplay between the virus and the liver's internal clock, we have taken a significant step towards understanding the pathogenesis of this disease. These findings offer promising avenues for future research and clinical applications, ultimately improving the lives of patients affected by HCV-related liver disease.

Please sign in or register for FREE

If you are a registered user on Research Communities by Springer Nature, please sign in

Follow the Topic

Systems Virology
Life Sciences > Biological Sciences > Microbiology > Virology > Systems Virology
Cellular Circadian Rhythms
Life Sciences > Biological Sciences > Cell Biology > Cellular Circadian Rhythms
Hepatology
Life Sciences > Health Sciences > Clinical Medicine > Gastroenterology > Hepatology
Liver fibrosis
Life Sciences > Health Sciences > Clinical Medicine > Diseases > Gastrointestinal Diseases > Liver Diseases > Liver fibrosis
Liver Cancer
Life Sciences > Biological Sciences > Cancer Biology > Cancers > Gastrointestinal Cancer > Liver Cancer
Hepatitis C virus
Life Sciences > Biological Sciences > Microbiology > Virology > Hepatitis C virus

Related Collections

With collections, you can get published faster and increase your visibility.

Biology of rare genetic disorders

This cross-journal Collection between Nature Communications, Communications Biology, npj Genomic Medicine and Scientific Reports brings together research articles that provide new insights into the biology of rare genetic disorders, also known as Mendelian or monogenic disorders.

Publishing Model: Open Access

Deadline: Jan 31, 2025

Advances in catalytic hydrogen evolution

This collection encourages submissions related to hydrogen evolution catalysis, particularly where hydrogen gas is the primary product. This is a cross-journal partnership between the Energy Materials team at Nature Communications with Communications Chemistry, Communications Engineering, Communications Materials, and Scientific Reports. We seek studies covering a range of perspectives including materials design & development, catalytic performance, or underlying mechanistic understanding. Other works focused on potential applications and large-scale demonstration of hydrogen evolution are also welcome.

Publishing Model: Open Access

Deadline: Dec 31, 2024